Tim Watkins
CMO & Head of Development, Contineum Therapeutics, Inc.
Companies
- Contineum Therapeutics, Inc.CMO & Head of Development Apr 28, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Contineum Therapeutics, Inc. CTNM8,961 shares2$63.4K at $7.08Jun 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Sold 10,833 shares at $16.02 of Contineum Therapeutics, Inc.2
- Jun 30, 2026Exercised options 10,833 shares at $4.50 of Contineum Therapeutics, Inc.2
- Mar 2, 2026Sold 3,611 shares at $15.02 of Contineum Therapeutics, Inc.3
- Mar 2, 2026Exercised options 3,611 shares at $4.50 of Contineum Therapeutics, Inc.3
- Jan 28, 2026Sold 811 shares at $14.48 of Contineum Therapeutics, Inc.4
- Jan 28, 2026Sold 2,800 shares at $14.09 of Contineum Therapeutics, Inc.4
- Jan 28, 2026Exercised options 3,611 shares at $4.50 of Contineum Therapeutics, Inc.4
- Dec 29, 2025Sold 3,611 shares at $12.06 of Contineum Therapeutics, Inc.5
- Dec 29, 2025Exercised options 3,611 shares at $4.50 of Contineum Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 2, 2026
- 4SEC EDGARForm 4 filed Jan 30, 2026
- 5SEC EDGARForm 4 filed Dec 30, 2025